# Efficacy and Safety of an Intelligent Insulin-Dosing Decision Support System for Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Study

Study · id `cardio:ct-nct07291804` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07291804](<https://clinicaltrials.gov/study/NCT07291804>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07291804

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

## Technical summary

Registry record NCT07291804. Randomized; single masking; primary purpose treatment. Start 2025-03-01 (actual); primary completion 2025-12-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 140 participants (enrolled count; ClinicalTrials.gov record NCT07291804, source copy `cardio:ctgov-nct07291804-2025-12-18`, retrieved 2026-10-26)
- Started: 2025-03-01 (actual) (ClinicalTrials.gov record NCT07291804, source copy `cardio:ctgov-nct07291804-2025-12-18`, retrieved 2026-10-26)
- Primary completion: 2025-12-01 (actual) (ClinicalTrials.gov record NCT07291804, source copy `cardio:ctgov-nct07291804-2025-12-18`, retrieved 2026-10-26)
- Completion: 2025-12-01 (actual) (ClinicalTrials.gov record NCT07291804, source copy `cardio:ctgov-nct07291804-2025-12-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07291804, source copy `cardio:ctgov-nct07291804-2025-12-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07291804-2025-12-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of an Intelligent Insulin-Dosing Decision Support System for Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Study
- Condition: Diabetes Mellitus，Type 2
- Intervention (Device): Intelligent Insulin-Dosing Decision Support System
- Lead sponsor: Third Affiliated Hospital, Sun Yat-Sen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Third Affiliated Hospital, Sun Yat-Sen University (`cardio:org-third-affiliated-hospital-sun-yat-sen-university`)

## Provenance

Content hash: a829b3a66e4de486a0352a6acc6dfedbdfdac6f7ed35eda082e6950c34c5d6aa
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
